| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate |
1996-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2002-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d45544800efab8e447aa057dd28e619a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef56752f2d6ba798cbb857912ab60f26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bb42a705ac0905e662894a6e2160fb2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2c18e45e02373937d71e13c7a4b7848
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb450c332d1e47b293170f227fa9039a |
| publicationDate |
2002-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DK-0877750-T3 |
| titleOfInvention |
Suitable hypogolesterolemic agents are sugar-substituted 2-azetidinones |
| priorityDate |
1995-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |